StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > A look at the map

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Apr 06, 2021 9:34am

114 Views

Post# 32940648

RE:RE:A look at the map

You probably didn't read what I've written, to get the big fish partnership like Mercer for Aristotle you need to be able to take care of patients when they test positive, it's a regulatory necessity in the US. Now we can since yesterday

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record